Attenuation of Lipopolysaccharide-Induced Inflammatory Response and Phospholipids Metabolism at the Feto-Maternal Interface by N-Acetyl Cysteine

• Published in: Pediatric research Vol. 64; no. 4; pp. 334 - 339
• Main Authors: Paintlia, Manjeet K, Paintlia, Ajaib S, Singh, Avtar K, Singh, Inderjit
• Format: Journal Article
• Language: English
• Published: New York Nature Publishing Group US 01-10-2008; Lippincott Williams & Wilkins
• Subjects: Acetylcysteine - therapeutic use; Animals; basic-science-investigation; Biological and medical sciences; Cyclooxygenase 2 - metabolism; DNA Primers - genetics; Female; General aspects; Immunoblotting; Immunoenzyme Techniques; Inflammation - drug therapy; Inflammation - immunology; Inflammation - microbiology; Lipid Peroxidation - physiology; Lipopolysaccharides - toxicity; Malondialdehyde - metabolism; Maternal-Fetal Exchange - physiology; Medical sciences; Medicine; Medicine & Public Health; Pediatric Surgery; Pediatrics; Phospholipids - metabolism; Placenta - immunology; Placenta - metabolism; Placenta - pathology; Pregnancy; Rats; Reverse Transcriptase Polymerase Chain Reaction; Response; Mucolytic; Pediatrics; Thiol; Fetomaternal; Acetylcysteine; Lipopolysaccharide; Phospholipid; Attenuation; Fetus; Inflammation; Metabolism
• ISSN: 0031-3998; 1530-0447
• DOI: 10.1203/PDR.0b013e318181e07c

Maternal microbial infections cause adverse fetal developmental outcomes including embryonic resorption, intrauterine fetal death, and preterm labor. Recent studies demonstrated that oxidative-stress plays an important role in chorioamniotitis pathogenesis. Herein we investigated the effect of
N
-acetyl cysteine (NAC) on lipopolysaccharide (LPS)-induced preterm labor and fetal demise in murine model. Lipopolysaccharide exposure at embryonic day 18 demonstrated an increase in the abortion rate and fetal demise in pregnant rats. This was associated with increase in an inflammatory response (cytokines, chemokines, and iNOS expression) and infiltration of leukocytes (monocytes and polymorphonuclear cells) in the placenta. There was increased expression of cytosolic and secretary phospholipase A2 with increased secretion of prostaglandin-2 and leukotriene B4 in the placenta, suggestive of increased metabolism of phospholipids. In addition, expression of cycloxygenase-2 and malondialdehyde production (oxidative-stress marker) was increased in the placenta. Conversely, NAC pretreatment abolished these effects of LPS in the placenta. Collectively, these data provide evidence that LPS-induced increased inflammation and metabolism of phospholipids at the feto-maternal interface (placenta) is critical for preterm labor and fetal demise during maternal microbial infections which could be blocked by antioxidant-based therapies.